Prevalence of Hypogonadism in Newly Onset Type 2 Diabetes Mellitus?- A Cross-sectional Study - Video

Published On 2022-10-28T09:15:08+05:30 | Updated On 28 Oct 2022 9:15 AM IST

Overview

Several cross-sectional studies worldwide have reported a high prevalence (20– 64%) of hypogonadism among males with diabetes mellitus. Association between hypogonadism and DM has recently been drawing public health attention. Hypogonadism (low testosterone) has been classically linked with sexual dysfunction. But recent data show that it is also linked with insulin resistance (IR), obesity, metabolic syndrome (MS), incident DM, dyslipidemia, cardiovascular disease, depression, and poor quality of life.

Despite all these, few studies on hypogonadism in newly onset DM are done from the Eastern part of India. So, the authors carried out a cross-sectional study to know the magnitude of the problem and predictor of hypogonadism in this part of India as ethnicity and lifestyle vary from region to region.

A total of 231 consecutive newly diagnosed males with type 2 DM were enrolled. Patients were stratified into group A (hypogonadal) and group B (eugonadal) based on TT level. Mean value of age, body mass index (BMI), A1c, waist circumference (WC), TC, TG, LDL, high-density lipoprotein (HDL), systolic blood pressure (SBP), diastolic blood pressure (DBP), uric acid (UA), and glomerular filtration rate (eGFR) in group A and group B were compared. It was found that the prevalence of hypogonadism was 38.53%.

Hence, it was concluded that the prevalence of hypogonadism is high in newly diagnosed DM. BMI, central obesity and triglyceride levels are significantly associated with low Testosterone. So obese and hyper- triglyceride patients should be evaluated for Testosterone levels at the time of diagnosis. These patients should be treated with drugs that promote weight loss, reduce insulin resistance, and raise Testosterone levels.

Reference:

Shailendra Kumar Singh, Rina Singh , Santosh Kumar Singh, Pradeep Kumar Rai. Prevalence and Predictor of Hypogonadism in Newly Onset Type 2 Diabetes Mellitus: A Cross-sectional Study. JAPI 2022; Vol 70.

Speakers

Dr. Nandita Mohan

BDS, MDS( Pedodontics and Preventive Dentistry)

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751